<--- Back to Details
First PageDocument Content
Medicine / Pharmaceutical industry / Drug discovery / Medical statistics / Nursing research / Food and Drug Administration / Clinical trial / Regulatory requirement / Translational medicine / Health / Pharmaceutical sciences / Pharmacology
Date: 2014-07-31 11:03:18
Medicine
Pharmaceutical industry
Drug discovery
Medical statistics
Nursing research
Food and Drug Administration
Clinical trial
Regulatory requirement
Translational medicine
Health
Pharmaceutical sciences
Pharmacology

Deloitte’s Path to 21st Century Cures — A Call to Action Introduction Our country has had a strong commitment to life sciences research and development (R&D) for new treatments and

Add to Reading List

Source URL: energycommerce.house.gov

Download Document from Source Website

File Size: 981,67 KB

Share Document on Facebook

Similar Documents

SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa

SL-35: Oncology Phenotypic Screening. Macrocycles. Phenotypic screening is a firmly established technology that has contributed to the identification of valuable therapeutic agents in oncology drug discovery [1]. For exa

DocID: 1voSH - View Document

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

Seminars on Drug Discovery & Development Wednesdays 17::00, Lecture Hall 1, Pharmazentrum, Klingelbergstrasse 50, Basel Feb 24, 16 Prof. Dr. G. Klebe, Institute of Pharmaceutical Chemistry, Philipps-University Mar

DocID: 1vnYL - View Document

THE SCIENCE OF BETTER MEDICINES The Harvard Program in Therapeutic Science (HiTS) is building partnerships and developing new ideas and technologies to advance drug discovery and precision medicine.

THE SCIENCE OF BETTER MEDICINES The Harvard Program in Therapeutic Science (HiTS) is building partnerships and developing new ideas and technologies to advance drug discovery and precision medicine.

DocID: 1vnKo - View Document

Scientific Program  conferenceseries.com 3rd International Conference and Expo on  Drug Discovery & Designing

Scientific Program conferenceseries.com 3rd International Conference and Expo on Drug Discovery & Designing

DocID: 1vngF - View Document

5th CDDD Meeting  COMPUTATIONALLY DRIVEN DRUG DISCOVERY  November 16-17, 2017 | IFOM, Milan - Italy

5th CDDD Meeting COMPUTATIONALLY DRIVEN DRUG DISCOVERY November 16-17, 2017 | IFOM, Milan - Italy

DocID: 1vkVj - View Document